Denver Niles

NPI: 1558748368
Total Payments
$26,401
2024 Payments
$26,282
Companies
2
Transactions
26

Payment Breakdown by Category

Travel$15,203 (57.6%)
Consulting$6,150 (23.3%)
Other$4,651 (17.6%)
Food & Beverage$397.21 (1.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $15,203 10 57.6%
Consulting Fee $6,150 1 23.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,651 4 17.6%
Food and Beverage $397.21 11 1.5%

Top Paying Companies

Company Total Records Latest Year
bioMerieux Inc $26,197 18 $0 (2024)
Astellas Pharma US Inc $203.60 8 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $26,282 21 bioMerieux Inc ($26,197)
2019 $95.84 4 Astellas Pharma US Inc ($95.84)
2018 $22.72 1 Astellas Pharma US Inc ($22.72)

All Payment Transactions

26 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/13/2024 bioMerieux Inc Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,706.00 General
11/13/2024 bioMerieux Inc Travel and Lodging Cash or cash equivalent $1,968.00 General
11/13/2024 bioMerieux Inc Travel and Lodging Cash or cash equivalent $211.71 General
11/13/2024 bioMerieux Inc Travel and Lodging Cash or cash equivalent $119.95 General
10/14/2024 Astellas Pharma US Inc Cresemba (Drug) Food and Beverage In-kind items and services $29.00 General
Category: Infectious Diseases
09/16/2024 Astellas Pharma US Inc Cresemba (Drug) Food and Beverage In-kind items and services $23.42 General
Category: Infectious Diseases
09/10/2024 bioMerieux Inc Consulting Fee Cash or cash equivalent $6,150.00 General
09/10/2024 bioMerieux Inc Travel and Lodging Cash or cash equivalent $566.39 General
09/10/2024 bioMerieux Inc Travel and Lodging Cash or cash equivalent $164.28 General
09/10/2024 bioMerieux Inc Food and Beverage Cash or cash equivalent $32.47 General
09/05/2024 bioMerieux Inc Travel and Lodging Cash or cash equivalent $1,476.00 General
09/05/2024 bioMerieux Inc Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $738.00 General
09/05/2024 bioMerieux Inc Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $100.00 General
09/05/2024 bioMerieux Inc Travel and Lodging Cash or cash equivalent $85.57 General
08/22/2024 bioMerieux Inc FilmArray BCID Panel (Device) Food and Beverage In-kind items and services $74.23 General
Category: Diagnostics
04/30/2024 bioMerieux Inc Travel and Lodging Cash or cash equivalent $5,904.00 General
04/30/2024 bioMerieux Inc Travel and Lodging Cash or cash equivalent $3,821.00 General
04/30/2024 bioMerieux Inc Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,107.00 General
04/30/2024 bioMerieux Inc Travel and Lodging Cash or cash equivalent $885.83 General
04/28/2024 bioMerieux Inc VITEK2 (Device) Food and Beverage In-kind items and services $86.91 General
Category: Diagnostics
04/15/2024 Astellas Pharma US Inc Cresemba (Drug) Food and Beverage In-kind items and services $32.62 General
Category: Infectious Diseases
11/15/2019 Astellas Pharma US Inc MYCAMINE (Drug) Food and Beverage In-kind items and services $24.43 General
Category: INFECTIOUS DISEASES
09/13/2019 Astellas Pharma US Inc AMBISOME (Drug), MYCAMINE Food and Beverage In-kind items and services $23.56 General
Category: INFECTIOUS DISEASES
05/14/2019 Astellas Pharma US Inc AMBISOME (Drug), MYCAMINE Food and Beverage In-kind items and services $24.65 General
Category: INFECTIOUS DISEASES
04/05/2019 Astellas Pharma US Inc AMBISOME (Drug), MYCAMINE Food and Beverage In-kind items and services $23.20 General
Category: INFECTIOUS DISEASES

About Denver Niles

Denver Niles is a Clinical Pathology/Laboratory Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2015. The National Provider Identifier (NPI) number assigned to this provider is 1558748368.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Denver Niles has received a total of $26,401 in payments from pharmaceutical and medical device companies, with $26,282 received in 2024. These payments were reported across 26 transactions from 2 companies. The most common payment nature is "Travel and Lodging" ($15,203).

Practice Information

  • Specialty Clinical Pathology/Laboratory Medicine
  • Other Specialties Student in an Organized Health Care Education/Training Program, Pediatric Infectious Diseases
  • Location Houston, TX
  • Active Since 04/30/2015
  • Last Updated 08/22/2022
  • Taxonomy Code 207ZP0105X
  • Entity Type Individual
  • NPI Number 1558748368

Products in Payments

  • AMBISOME (Drug) $94.13
  • VITEK2 (Device) $86.91
  • Cresemba (Drug) $85.04
  • FilmArray BCID Panel (Device) $74.23
  • MYCAMINE (Drug) $24.43

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Clinical Pathology/Laboratory Medicine Doctors in Houston